Bursa’s First IVF Center

Bursa Eurofertil IVF Center opened in 2005 as Bursa IVF Center and joined the Eurofertil group in 2015. As Bursa’s first IVF center, Bursa Eurofertil IVF Center has been successfully serving patients in the same building for 18 years, offering every level of care from the simplest tests and treatments to the most complex reproductive technologies with its team of specialists.

Bursa Eurofertil IVF Center closely follows every proven treatment method and the latest technology, working to help you hold your baby in your arms as soon as possible, with pregnancy rates that even surpass the world’s best average, that of the United States.

Is There State Support for IVF Treatment?

There is support from the Social Security Institution (SGK) for IVF treatment. Our patients who are covered by SGK and need IVF treatment can obtain a report stating that “IVF treatment is appropriate” from a Training and Research Hospital or University Hospital with an IVF department, provided they meet the conditions published by SGK below.

Patients who obtain this report can benefit from the SGK discount and have their treatment carried out at our clinic when they apply with this report.

Bursa’s SGK-Contracted IVF Center

As Bursa Eurofertil IVF Center, we have an agreement with the Social Security Institution (SGK). Patients who obtain a report stating that IVF treatment is appropriate can use this report at our clinic and benefit from the SGK discount.

Patients can obtain the IVF report as a medical board report by applying to the IVF centers of state hospitals or university hospitals.

The basic conditions required to obtain this report are:

The prospective mother must be older than 23 and not yet have turned 40.
One of the spouses must have at least 900 days of SGK premium payments and at least 5 years of insurance coverage.
The couple must not have children from their current marriage. Children from previous marriages do not prevent them from obtaining this report.
Unless there is a specific condition such as a tubal factor, the couple must have been married for at least 3 years.

Patients who meet these conditions can receive discounted treatment at our clinic once they have obtained their report.

What Is the Advantage of Bursa Eurofertil?

Bursa Eurofertil IVF Center, founded in 2005, is Bursa’s first IVF center. Having joined the Eurofertil group in 2015, our center has become even stronger. For 18 years, in the same building, it has offered our patients every diagnostic and treatment protocol under one roof, from the simplest procedure to the most complex.

Bursa Eurofertil IVF Center works to offer its patients the best, thanks to the knowledge and experience gained to date. Our center is not a hospital environment; it is a stand-alone facility designed specifically for the diagnosis and treatment of infertility.

As a team, we understand you very well and work to help you take your baby home with the highest chance of pregnancy.

Our embryology laboratory always uses the latest technology, and we pioneer every necessary innovation. With our specialist physicians, embryologists, and nurses, we always work to do our best for your dreams.

We take pride in being the first center in Bursa to apply many methods, such as vitrification, the embryoscope, and the trophectoderm biopsy witnessing system.

We are always by your side to help you go through a stressful process like IVF treatment in peace and confidence.

We regard our patients as family, and we share the joy of becoming one big family with the children who are born.

Social Security Institution Health Implementation Communiqué (SUT 2012)

2.4.4.İ - Assisted reproduction treatments

(1) In vitro fertilization procedures (IVF) are considered an “assisted reproduction method” as defined in Article 63 of Law No. 5510. Ovulation induction (OI) and intrauterine insemination (IUI) are not considered within this scope.

2.4.4.İ.1 - In Vitro Fertilization (IVF)

The costs of IVF treatments, applied to a general health insurance holder woman who, regardless of whether she has children from a previous marriage (excluding adopted children), has no children from her current marriage, or applied to the wife of a man who is a dependent of his general health insurance, and limited to a maximum of three attempts (cycles), shall be covered by the Institution provided the following conditions are met together.

a) A health board report must have been issued stating that, following medical treatments, the couple could not have a child through normal medical methods and could only have a child through an assisted reproduction method,

b) The woman must have turned 23 and be younger than 39,

c) The center where the procedure is performed must be contracted/protocoled with the Institution,

ç) The person must have been a general health insurance holder or a dependent for at least five years and have at least 900 days of general health insurance premium payments, or, if the currently insured woman does not meet these conditions, her spouse must meet the required conditions,

d) It must be documented by the health boards of a health service provider contracted/protocoled with the Institution that no results were obtained from other treatment methods within the last three years.

(2) If the woman starting IVF treatment has turned 40 by the date of the IVF procedure (the date the embryo transfer is performed), the costs of the IVF treatment shall not be covered by the Institution. However, if there is a valid health report issued before the date the woman turned 40, and the embryo transfer is performed within 30 days of the date of the report, the health services related to the IVF treatment shall be covered by the Institution.

(3) IVF treatments previously paid for by social security institutions transferred to the Institution are taken into account when calculating the number of attempts.

(4) In order for IVF costs to be paid, it is sufficient that the health board report required for the IVF treatment states that the woman undergoing IVF has no systemic disease that could prevent the continuation of pregnancy.

2.4.4.İ-1-1 - IVF indications

1) Male factor: Oligoasthenospermia cases where, despite uro-andrological treatment, the total progressive motile sperm count is less than 5 million in all three separate semen analyses performed at least 15 days apart, as well as azoospermia cases. However, if it is documented by a specialist physician’s report that a condition prevents obtaining ejaculate/sperm through normal means, a semen analysis result is not required.

2) Female factor:

a) Tubal factor: Primary ciliary dyskinesia/Kartagener Syndrome, cases of bilateral complete tubal occlusion confirmed by laparoscopy (severe distal tubal disease, bilateral organic proximal tubal occlusion, bilateral tubal occlusion, or absence of tubes), cases of severe pelvic adhesion, or cases that fail to conceive after tubal surgery (laparoscopic or open surgery).

b) Endometriosis: Mild and moderate endometriosis, advanced-stage (stage 3-4) endometriosis.

c) Hormonal/ovulatory disorders: WHO Group I-II patients unresponsive to standard treatment for anovulation.

3) Unexplained infertility: Failure to conceive for 3 years or longer from the date of marriage, despite both the man’s and the woman’s tests being normal and at least two attempts of OI+IUI with gonadotropins.

4) Other indications: Cases with poor ovarian response or low ovarian reserve.

2.4.4.İ-1-2 - IVF health board report

(1) The health board report required for IVF treatment shall be issued by health boards formed with the participation of two obstetrics and gynecology specialists and one urology specialist, at tertiary-level health institutions that have both an obstetrics and gynecology clinic and a urology clinic (including obstetrics and gynecology training hospitals that do not have a urology clinic but where a urology specialist serves as a consultant).

(2) Health board reports shall state the patient’s age, identity information, diagnosis, indication, and the treatment to be applied; in addition, the daily and maximum doses of the medications to be used shall also be included in the health board reports, taking into account the provisions of Article 4.2.42.B of the SUT.

(3) The health board report must state:

a) For male factor, that despite two attempts of “OI+IUI” treatment with gonadotropins, pregnancy was not achieved in cases of oligoasthenozoospermia with a total progressive motile sperm count above 5 million (this condition is not required for oligoasthenozoospermia cases below 5 million or azoospermia cases),

b) For advanced-stage (stage 3-4) endometriosis cases, that pregnancy was not achieved one year after endometriosis surgery, or after two attempts of “OI+IUI” treatment with gonadotropins following surgical treatment,

c) For mild and moderate endometriosis cases, that pregnancy was not achieved after at least two attempts of “OI+IUI” treatment with gonadotropins,

ç) For unexplained infertility cases, that pregnancy was not achieved after at least two attempts of “OI+IUI” treatment with gonadotropins,

must be stated.

(4) However, prior “OI and/or OI+IUI” treatment before IVF is not required, provided the clinical and laboratory findings supporting the diagnosis are stated in the health board report, in cases of:

a) Primary ciliary dyskinesia/Kartagener Syndrome,

b) Bilateral complete tubal occlusion confirmed by laparoscopy (severe distal tubal disease, bilateral organic proximal tubal occlusion, bilateral tubal occlusion, or absence of tubes),

c) Severe pelvic adhesion or failure to conceive within one year after tubal surgery (laparoscopic or open surgery),

ç) WHO Group I-II patients unresponsive to standard treatment for anovulation.

(5) If the IVF procedure is not performed within 6 months of the date the health board report was issued, a new health board report must be issued. However, if medications were procured within this period, the medications procured shall be taken into account in the maximum dose calculation.

(6) A health board report is required for each IVF treatment.

2.4.4.İ-2 - IVF treatment for the birth of a stem cell donor sibling

(1) If a patient already has a child whose treatment is not possible by any other medical method and is medically necessary, the costs of IVF treatments performed for the purpose of the birth of a suitable stem cell donor sibling through preimplantation genetic screening, based on a health board report issued in the name of the sick child by the health boards of tertiary-level health service providers with a bone marrow transplant center, including a geneticist and stating these circumstances, shall be covered by the Institution without applying the provisions of Article 2.4.4.İ-1 of the SUT. Other than this circumstance, the costs of preimplantation genetic screening and the IVF performed together with this procedure shall not be covered by the Institution.

(2) Families may apply to one of the assisted reproduction treatment centers (IVF centers) contracted/protocoled with the Institution based on the health board report in question.

(3) The provisions of Article 4.2.42.C of the SUT apply to the medication doses determined by the Health Board report.

2.4.4.İ.1.3 - Payment of IVF treatment costs

(1) IVF treatment shall be invoiced based on the fee specified in Annex EK-2/C of the SUT. This fee includes ovulation monitoring, oocyte aspiration, sperm/oocyte preparation and incubation, ICSI (micro-injection), invasive sperm retrieval methods, examination and test fees performed on the woman and man before the procedure, all consumables used, and the embryo transfer.

(2) The embryo freezing fee can only be invoiced, after the first attempt, based on the fee specified in Annex EK-2/B of the SUT.

(3) If the IVF procedure cannot be performed on the patient, the procedures performed up to that point shall be invoiced with a 10% discount based on Annex EK-2/B of the SUT. In this case, these procedures shall not be included in the number of attempts. However, the medications used shall be taken into account in the maximum dose calculation.

(4) If the IVF treatment is performed with the transfer of a frozen embryo, the procedures shall be invoiced based on the “Transfer of a frozen embryo” procedure specified in Annex EK-2/C of the SUT. In this case, this procedure shall be included in the number of attempts.

(5) Except in cases where the reason is documented by the physician performing the procedure, such as age factor, embryo quality, and similar medical necessities, the health service costs arising from multiple births resulting from the transfer of more than one embryo, up to the discharge of the babies, shall not be covered by the Institution. If the treatment of these babies is performed at a contracted/protocoled health service provider other than the one that performed the embryo transfer, these costs shall be covered by the Institution but shall be deducted from the payments made to the center that performed the embryo transfer.

2.4.4.İ.1.4 - Keeping of records

(1) At assisted reproduction treatment centers contracted/protocoled with the Institution, it is mandatory to keep records of all medical procedures performed within the scope of IVF and to present these records during audits. The center manager and the holders of the license (certificate of conformity) are jointly and severally responsible for keeping and preserving these records accurately and properly.

(2) A certified copy of the family register showing whether married couples have children shall be kept in the patient file maintained at the center.

How Do I Make an IVF Appointment?

You can always reach us by phone at 0224 251 50 00, by WhatsApp at 0530 886 52 63, or through our website. Our call center team will always be happy to help you with any question. During your treatment, you can call our coordinator and nurses with your questions. The most important thing during treatment is not to use medications incorrectly. Please do not hesitate to call us with all your questions, so as not to jeopardize your treatment by mistake.

Join the team that makes a difference